Type 2 Diabetes Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Type 2 Diabetes Market Size Likely To Evolve From 2025 Through 2034?

The type 2 diabetes market has seen significant expansion in recent years. This market is forecast to increase from $48.14 billion in 2024 to $51.47 billion in 2025, at a compound annual growth rate (CAGR) of 6.9%. Throughout the historic period, this growth can be attributed to evolving lifestyle and dietary habits, an aging demographic, innovations in pharmaceuticals, and various public health initiatives.

The type 2 diabetes market is anticipated to witness significant expansion over the next few years. It is projected to reach $71.31 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.5%. The projected increase during this period is largely due to the global diabetes epidemic, developments in personalized medicine, technological advancements, and evolving healthcare policy changes. Notable trends expected in the forecast period include the rise of digital health and telemedicine, a focus on prevention and early intervention, the integration of artificial intelligence (AI) and machine learning (ML), and the increasing adoption of metabolic surgery.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13050&type=smp

What Are The Top Growth Drivers Impacting The Type 2 Diabetes Market Outlook?

The future expansion of the type 2 diabetes market is anticipated to be driven by escalating incidences of obesity and heart disease. Obesity is defined as an unhealthy accumulation of excess body fat, whereas heart disease encompasses various ailments impacting the heart and its associated blood vessels. Excessive body weight elevates the likelihood of insulin resistance, resulting in elevated blood sugar and the onset of type 2 diabetes. Conversely, persistently high blood sugar levels can harm the blood vessels and nerves vital for heart function, thereby contributing to heart disease. For example, the World Health Organization (WHO), an intergovernmental body based in Switzerland, disclosed in March 2024 that roughly one in eight individuals globally were affected by obesity. This figure encompassed 2.5 billion adults (aged 18 years and above) who were overweight, with 890 million of these individuals classified as obese. Specifically, 43% of adults were overweight, and 16% were considered obese. Furthermore, 37 million children under the age of 5 were reported as overweight. Consequently, the escalating prevalence of obesity and heart disease is fueling the expansion of the type 2 diabetes market.

What Are The Major Segments Identified In The Type 2 Diabetes Market?

The type 2 diabetesmarket covered in this report is segmented –

1) By Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors; Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists; Thiazolidinediones; Alpha-Glucosidase Inhibitors; Sulfonylureas And Other Insulin Secretagogues; Biguanides; SodiumGlucose Cotransporter 2 Inhibitors; Other Drug Classes

2) By Application: Glycemic Control; Cardiovascular Safety; Hypoglycemia Avoidance; Other Applications

3) By End-User: Children; Adults

Subsegments:

1) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin; Saxagliptin; Linagliptin; Alogliptin

2) By Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Liraglutide; Semaglutide; Dulaglutide; Exenatide

3) By Thiazolidinediones: Pioglitazone; Rosiglitazone

4) By Alpha-Glucosidase Inhibitors: Acarbose; Miglitol

5) By Sulfonylureas And Other Insulin Secretagogues: Glimepiride; Glipizide; Glyburide

6) By Biguanides: Metformin

7) By Sodium-Glucose Cotransporter 2 Inhibitors: Canagliflozin; Dapagliflozin; Empagliflozin

8) By Other Drug Classes: Amylin Analogues; Bile Acid Sequestrants; Dopamine Agonists

Which Competitive Trends Are Defining The Type 2 Diabetes Market Structure?

Leading companies in the type 2 diabetes market are developing advanced products, such as Mounjaro, to establish improved safety and effectiveness standards for diabetic patients. Innovative medications like Mounjaro aim to enhance the efficacy, safety, or convenience of diabetes management compared to existing therapies. Developments in diabetes drug research focus on improving blood sugar control, reducing side effects, and addressing other related health issues. For instance, in May 2022, Eli Lilly and Co., a US-based pharmaceutical company, received approval from the U.S. Food and Drug Administration, a US-based government organization, for Mounjaro (tirzepatide) injection to enhance blood sugar control in adults with type 2 diabetes when used alongside diet and exercise. Tirzepatide is a novel, dual-targeted treatment for type 2 diabetes. This once-weekly injection targets two hormones involved in blood sugar regulation, specifically glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). GLP-1 helps increase insulin production and decrease glucagon production, while GIP contributes to increased insulin production. Tirzepatide represents a promising new treatment option for individuals with type 2 diabetes, even those who have not responded adequately to other treatments.

Which Leading Companies Dominate The Type 2 Diabetes Market Share?

Major companies operating in the type 2 diabetes market are F. Hoffmann-La Roche AG, Merck and Co. Inc., Novartis AG, AstraZeneca PLC, Abbott Laboratories, Sanofi SA, Medtronic PLC, Takeda Pharmaceutical Company, GlaxoSmithKline plc., Eli Lilly and Company, Novo Nordisk A/S, Johnson And Johnson Private Limited, Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Dexcom Inc., Amgen Inc., Insulet Corporation, Ascensia Diabetes Care, Byram Healthcare, Beta Bionics, Onduo LLC, DarioHealth, One Drop, Bigfoot Biomedical Inc., Digbi Health, MySugr GmbH, Senseonics Holdings Inc., Provention Bio Inc., Vida Health Inc., Diathrive Health.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/type-2-diabetes-global-market-report

How Do Regional Market Performances Compare Within The Type 2 Diabetes Industry?

North America was the largest region in the type 2 diabetes market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in type 2 diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Type 2 Diabetes Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13050&type=smp

Browse Through More Reports Similar to the Global Type 2 Diabetes Market 2025, By The Business Research Company

Digital Diabetes Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

Diabetes Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

Pet Diabetes Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795